Evidence map›Paper›PMID 40888982›Full record

ArticleMycopathologia2025

Expansion of the Candidozyma haemuli Species Complex - The Novel Species Candidozyma molenica, Isolated from Clinical and Environmental Sources.

Annemarie Zandijk, Tjomme van der Bruggen, Matthias Sipiczki, Wim J E Tissing, Tom F W Wolfs, Bert Gerrits van den Ende, Marizeth Groenewald, Ferry Hagen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mycopathologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Silent Outbreaks ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Annemarie ZandijkDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute (WI-KNAW), Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.ORCID http://orcid.org/0009-0001-9742-981X
Tjomme van der BruggenDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-5306-7677
Matthias SipiczkiDepartment of Genetics and Applied Microbiology, University of Debrecen, Debrecen, Hungary.ORCID http://orcid.org/0000-0002-1059-1305
Wim J E TissingPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-9101-507X
Tom F W WolfsPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-2986-8404
Bert Gerrits van den EndeDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute (WI-KNAW), Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4439-3494
Marizeth GroenewaldDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute (WI-KNAW), Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-0835-5925
Ferry HagenDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute (WI-KNAW), Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands. f.hagen@wi.knaw.nl.ORCID http://orcid.org/0000-0002-5622-1916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the recent unprecedented global rise of Candidozyma auris in hospital environments the members of the Candidozyma haemuli species complex have raised significant interest of clinicians and researchers. Until the finding of C. auris, the species complex did not receive much attention as the known pathogenic species were only rarely encountered in hospitals and clinical diagnostic laboratories. During the past years several new species were described, such as Candidozyma khanbhai and Candidozyma vulturna, that were found to be of clinical importance. Here, we used phylogenetic and phenotypic analyses -including antifungal susceptibility testing- to characterize and describe a new and potentially clinically relevant yeast that we obtained from clinical specimen and flowers, representing the proposed novel species Candidozyma molenica.

Indexed as

Environmental MicrobiologyMycosesAntifungal AgentsCluster AnalysisDNA, FungalDNA, RibosomalDNA, Ribosomal SpacerFlowersHumansMicrobial Sensitivity TestsPhylogenySequence Analysis, DNAAntifungal AgentsDNA, FungalDNA, RibosomalDNA, Ribosomal SpacerCandidozyma aurisCandidozyma haemuli species complexCandidozyma khanbhaiCandidozyma vulturnaEmerging pathogenMisidentification

Identifiers

PMID40888982
PMCPMC12402029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.